Elanco (ELAN) Q4-25 earnings: Phantom debt, the $202M cleanup & the vet bill squeeze

Despite a massive $276M net loss, Elanco’s Q4 2025 earnings sent the stock surging 9% as the market priced in record innovation revenues over a legacy accounting cleanup.In ~10 minutes:- Why a nameless $47M impairment is hiding in the restructuring math.- The 16.2% "phantom interest" charge severely skewing the balance sheet.- How an aggressive product bundling strategy is boxing out competitors.- Why your vet bill is seeing a five-year record price hike.Elanco is currently walking a tightrope, offsetting an enormous $202M quarterly cleanup charge with sheer top-line momentum from its core vet blockbusters. But with low-margin farm volumes pulling down gross profits and federal agriculture subsidies freezing, management is cleverly lowballing 2026 guidance to give themselves a built-in cushion for the second half of the year. Elanco Animal Health Incorporated (ELAN) | Q4 FY2025AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.